Additionally, we also found that GRAMD3 can distinguish Braak NFT stage in AD samples from EC tissues, which can explain that it may be involved in early cognitive decline symptoms through cerebrovascular disease (Dubé et al., 2013). The gene discussed is GRAMD2B; the disease is Alzheimer disease.